Table 1.
Distribution of clinical co-variates.
| Cohort | GSE117556 | GSE31312 | P-value |
|---|---|---|---|
| Sample | 928 | 470 | |
| Male | 517 (56%) | 271 (58%) | 0.23 |
| Age > 65 | 457(49%) | 207 (44%) | 0.07 |
| Sub-types | 0.02 | ||
| GCB | 475 (51%) | 227 (48%) | |
| ABC | 244 (26%) | 199 (42%) | |
| NA | 209 (23%) | 44 (9%) | |
| Stage | NA | ||
| Stage I | 27 (3%) | NA | |
| Stage II | 259 (28%) | NA | |
| Stage III | 283 (31%) | NA | |
| Stage IV | 355 (38%) | NA | |
| NA | 4 (0%) | NA | |
| IPI | 0.80 | ||
| Low | 246 (27%) | 169 (36%) | |
| Low-intermediate | 236 (25%) | 105 (22%) | |
| Intermediate-high | 281 (30%) | 92 (20%) | |
| High | 165 (18%) | 58 (12%) | |
| NA | NA | 46 (10%) |
NA, Not available.